Updated Clinical Practice Guidelines for the Diagnosis and Management of Long COVID

Abstract

"Long COVID" is a term used to describe a condition when the symptoms and signs associated with coronavirus disease 2019 (COVID-19) persist for more than three months among patients infected with COVID-19; this condition has been reported globally and poses a serious public health issue. Long COVID can manifest in various forms, highlighting the need for appropriate evaluation and management by experts from various fields. However, due to the lack of clear clinical definitions, knowledge of pathophysiology, diagnostic methods, and treatment protocols, it is necessary to develop the best standard clinical guidelines based on the scientific evidence reported to date. We developed this clinical guideline for diagnosing and treating long COVID by analyzing the latest research data collected from the start of the COVID-19 pandemic until June 2023, along with the consensus of expert opinions. This guideline provides recommendations for diagnosis and treatment that can be applied in clinical practice, based on a total of 32 key questions related to patients with long COVID. The evaluation of patients with long COVID should be comprehensive, including medical history, physical examination, blood tests, imaging studies, and functional tests. To reduce the risk of developing long COVID, vaccination and antiviral treatment during the acute phase are recommended. This guideline will be revised when there is a reasonable need for updates based on the availability of new knowledge on the diagnosis and treatment of long COVID.

Effectiveness of post-COVID-19 primary care attendance in improving survival in very old patients with multimorbidity: a territory-wide target trial emulation

“… 36 For example, respiratory rehabilitation therapy is recommended for patients with previous neurological and muscular comorbidity. 37 Finally, the enhancement of self-management specific to the current diseases or symptoms through primary care follow-up empowers patients to actively participate in their own healthcare and achieve improved outcomes. 38 39 …”

Kidney Function Tests and Continuous eGFR Decrease at Six Months after SARS-CoV-2 Infection in Patients Clinically Diagnosed with Post-COVID Syndrome

“…Patients eligible for inclusion in this study were individuals aged 18 years or older who had a laboratory-confirmed SARS-CoV-2 infection, verified either by RT-PCR or rapid antigen tests. Additionally, these individuals must have been diagnosed with Post-COVID Syndrome, characterized by a constellation of symptoms persisting for more than 12 weeks after the acute infection, according to guidelines [19]. These symptoms include, but are not limited to, chronic fatigue, shortness of breath, cognitive disturbances ("brain fog"), joint pain, and ongoing loss of taste or smell, without any alternative diagnosis that could explain these symptoms [20].…”